PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-22.13%
Revenue decline while CSIQ shows 31.40% growth. Joel Greenblatt would examine competitive position erosion.
-28.27%
Cost reduction while CSIQ shows 34.14% growth. Joel Greenblatt would examine competitive advantage.
71.96%
Gross profit growth exceeding 1.5x CSIQ's 21.20%. David Dodd would verify competitive advantages.
120.84%
Margin expansion while CSIQ shows decline. John Neff would investigate competitive advantages.
-56.68%
R&D reduction while CSIQ shows 29.50% growth. Joel Greenblatt would examine competitive risk.
-36.64%
G&A reduction while CSIQ shows 21.20% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-43.02%
Operating expenses reduction while CSIQ shows 17.32% growth. Joel Greenblatt would examine advantage.
-30.32%
Total costs reduction while CSIQ shows 31.51% growth. Joel Greenblatt would examine advantage.
-16.07%
Interest expense reduction while CSIQ shows 5.64% growth. Joel Greenblatt would examine advantage.
-29.50%
D&A reduction while CSIQ shows 0.00% growth. Joel Greenblatt would examine efficiency.
539.41%
EBITDA growth exceeding 1.5x CSIQ's 13.95%. David Dodd would verify competitive advantages.
664.31%
EBITDA margin growth while CSIQ declines. John Neff would investigate advantages.
71.69%
Operating income growth exceeding 1.5x CSIQ's 29.86%. David Dodd would verify competitive advantages.
63.64%
Operating margin growth while CSIQ declines. John Neff would investigate advantages.
400.69%
Other expenses growth while CSIQ reduces costs. John Neff would investigate differences.
554.91%
Pre-tax income growth while CSIQ declines. John Neff would investigate advantages.
741.05%
Pre-tax margin growth while CSIQ declines. John Neff would investigate advantages.
1297.03%
Tax expense growth above 1.5x CSIQ's 131.85%. Michael Burry would check for concerning trends.
130.29%
Net income growth while CSIQ declines. John Neff would investigate advantages.
195.75%
Net margin growth while CSIQ declines. John Neff would investigate advantages.
116.67%
EPS growth while CSIQ declines. John Neff would investigate advantages.
100.00%
Diluted EPS growth while CSIQ declines. John Neff would investigate advantages.
0.06%
Share count reduction exceeding 1.5x CSIQ's 0.64%. David Dodd would verify capital allocation.
3.38%
Diluted share reduction below 50% of CSIQ's 1.73%. Michael Burry would check for concerns.